Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02190669 · ClinicalTrials.gov registry record
Exercise and Diabetes - an Observational Study of Exercise and Blood Glucose Control
A clinical trial of Type 2 Diabetes and Type 1 Diabetes, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT02190669 is a study of Type 2 Diabetes and Type 1 Diabetes that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 12 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02190669, a study of Type 2 Diabetes and Type 1 Diabetes, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal seeks to gather continuous blood glucose and physical activity data from individuals with and without diabetes.
Conditions Studied
Interventions
- OTHER exercise
Study Locations (1)
California
- Sansum Diabetes Research Institute - Santa Barbara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02190669
The ClinicalTrials.gov registry entry for NCT02190669 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which exercise is the first listed.
NCT02190669 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02190669 about?
NCT02190669 is a clinical study titled "Exercise and Diabetes - an Observational Study of Exercise and Blood Glucose Control". This proposal seeks to gather continuous blood glucose and physical activity data from individuals with and without diabetes.
What is the current status of trial NCT02190669?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2014-06. Estimated completion is 2014-07.
What conditions does trial NCT02190669 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Type 1 Diabetes.
What interventions are being tested in trial NCT02190669?
The interventions under investigation include: exercise (OTHER).
Who is sponsoring clinical trial NCT02190669?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02190669 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
Mechanism of SGLT2 Inhibition in the Kidney
RECRUITING · Phase 4
-
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.